We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
Cap. Flow
-$507M
Cap. Flow %
-1.06%
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$262M
2
CVS icon
CVS Health
CVS
+$240M
3
MA icon
Mastercard
MA
+$204M
4
MCK icon
McKesson
MCK
+$201M
5
TAP icon
Molson Coors Class B
TAP
+$171M

Sector Composition

Rank Sector Weight
1 Healthcare 14.83%
2 Communication Services 13.94%
3 Technology 12.15%
4 Financials 10.5%
5 Energy 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEMV icon
801
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.41B
$99K ﹤0.01%
1,650
VR
802
DELISTED
Validus Hold Ltd
VR
$97K ﹤0.01%
+2,552
New +$95K
WTW icon
803
Willis Towers Watson
WTW
$29.9B
$96K ﹤0.01%
842
IWS icon
804
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$95K ﹤0.01%
1,309
+409
+45% +$28.5K
HBAN icon
805
Huntington Bancshares
HBAN
$35B
$94K ﹤0.01%
+9,882
New +$93K
CYHHZ
806
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$94K ﹤0.01%
1,410,118
+248,416
+21% +$16.2K
CODE
807
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
$94K ﹤0.01%
4,500
-3,500
-44% -$66.4K
SHLO
808
DELISTED
Shiloh Industries Inc
SHLO
$92K ﹤0.01%
+5,000
New +$93.9K
RSH
809
DELISTED
RADIOSHACK CORP
RSH
$88K ﹤0.01%
89,344
HTGC icon
810
Hercules Capital
HTGC
$3.04B
$80K ﹤0.01%
5,000
GSS
811
DELISTED
Golden Star Resources Ltd.
GSS
$80K ﹤0.01%
27,178
-15,000
-36% -$43K
RAS
812
DELISTED
RAIT Financial Trust
RAS
$80K ﹤0.01%
9,680
CNI icon
813
Canadian National Railway
CNI
$78.3B
$79K ﹤0.01%
1,230
STI
814
DELISTED
SunTrust Banks, Inc.
STI
$77K ﹤0.01%
1,944
-99
-5% -$3.85K
UVV icon
815
Universal Corp
UVV
$1.36B
$76K ﹤0.01%
1,383
MKL icon
816
Markel Group
MKL
$25.5B
$75K ﹤0.01%
115
TIME
817
DELISTED
Time Inc.
TIME
$72K ﹤0.01%
+3,019
New +$70.7K
QIHU
818
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
$72K ﹤0.01%
+786
New +$69.3K
VBK icon
819
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$70K ﹤0.01%
550
SQNM
820
DELISTED
SEQUENOM INC NEW
SQNM
$69K ﹤0.01%
18,000
-11,970
-40% -$35K
EWC icon
821
iShares MSCI Canada ETF
EWC
$6.18B
$67K ﹤0.01%
2,085
-1,109
-35% -$34K
CBD
822
DELISTED
Companhia Brasileira de Distribuicao
CBD
$66K ﹤0.01%
1,441
ARO
823
DELISTED
Aeropostale Inc
ARO
$66K ﹤0.01%
19,000
SFL icon
824
SFL Corp
SFL
$1.61B
$65K ﹤0.01%
3,520
VBR icon
825
Vanguard Small-Cap Value ETF
VBR
$37.7B
$64K ﹤0.01%
610

Similar funds

Lazard Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.

  • Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
  • Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
  • Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
  • Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
  • Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
  • Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
  • Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.

Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.